Whitehawk Therapeutics, Inc. (WHWK) Misses Q2 EPS by 101c
Tweet
Share
E-mailGet Alerts WHWK Hot Sheet
Join SI Premium – FREE
Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q2 EPS of ($0.76), $1.01 worse than the analyst estimate of $0.25.
For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- loanDepot receives NYSE non-compliance notice over stock price
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
